(Reuters) - Swiss drugmaker Novartis has appointed new heads of its eyecare business Alcon and generics division Sandoz, the group’s second and third largest businesses after pharmaceuticals.
Jeff George, who previously led Sandoz, will replace retiring Kevin Buehler as head of Alcon, effective May 1, Novartis said on Wednesday.
Help employers find you! Check out all the jobs and post your resume.
